Medpace Voice

As cardiovascular clinical trials evolve, imaging biomarkers have become essential tools for enriching patient populations, evaluating therapeutic response and accelerating...

At Medpace, we remain committed to shaping the future of cardiovascular care through our ongoing work with sponsors and research...

From protocol development to timely recruitment and retention to regulatory approval, it is crucial that trial subjects feel involved, retain their autonomy, and understand the…

In an upcoming webinar, leading cardiovascular experts delve into the realm of cardiovascular devices, assessing their potential to redefine the trajectory of heart failure, ultimately…

Register now for this upcoming webinar on July 25th at 11:00am EDT, in which featured speakers from Medpace share integrated approaches to include patients with…

Join our featured speakers as they discuss challenges and considerations surrounding the recruitment and retention of diverse patient populations to ensure appropriate representation in clinical research.

Medpace’s experts will be discussing important topics from both a medical and operational perspective.

We recognize the importance of the emerging role of precision medicine in the field of cardiovascular disease. To optimize support in the design and execution…

Experts in Familial hypercholesterolemia (FH) from the Medpace Central Lab were authors on a scientific poster presented at the American College of Cardiology’s 2018 Annual…

As part of Medpace’s ongoing partnership with the American Heart Association, we are delighted to once again announce our participation in the 2018 Heart Mini…